Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
AssigneeE. R. Squibb & Sons, Inc.
InventorsDonald S. Karanewsky, Jeffrey A. Robl
Life of this patent
Estimating the term…
Abstract
Compounds of the formula ##STR1## are disclosed as possessing inhibitory activity against angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) and thus being useful as cardiovascular agents. Processes for preparing these compounds are also disclosed.
Claims20
A compound of the formula ##STR54## and pharmaceutically acceptable salts thereof wherein:
- R.sub.1 is hydrogen, ##STR55## or R.sub.18 --S--;
- R.sub.2 and R.sub.19 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl--(CH.sub.2).sub.m --, substituted alkyl, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m -- or R.sub.2 and R.sub.19 taken together with the carbon atom to which they are attached complete a cycloalkyl ring or a benzofused cycloalkyl ring;
- n is zero or one;
- m is zero or an integer from 1 to 6;
- R.sub.3 is alkyl, substituted alkyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or heteroaryl-(CH.sub.2).sub.m --;
- R.sub.18 is alkyl, substituted alkyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or --S--R.sub.18 completes a symmetrical disulfide wherein R.sub.18 is of the formula ##STR56## X.sub.1 is of the formula ##STR57## R.sub.4 and R.sub.5 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m --, or one of R.sub.4 and R.sub.5 is hydrogen and the other is hydroxy, or R.sub.4 and R.sub.5 together with the carbon to which they are attached complete a keto substituent;
- R.sub.6 and R.sub.10 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, cycloalkyl --(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m --;
- R.sub.7 and R.sub.11 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, cycloalkyl --(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m -- and heteroaryl-(CH.sub.2).sub.m --;
- b is zero or one;
- R.sub.12 is hydrogen, alkyl, substituted alkyl, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, heteroaryl-(CH.sub.2).sub.m --, or ##STR58## R.sub.14 is hydrogen, lower alkyl, cycloalkyl, or phenyl;
- R.sub.15 is hydrogen, lower alkyl, lower alkoxy, or phenyl;
- the term "alkyl" refers to straight and branched chain radicals having one to seven carbon atoms;
- the term "substituted alkyl" refers to such straight or branched chain radicals of 1 to 7 carbons wherein one or more hydrogens have been replaced by a hydroxy, amino, halo, trifluoromethyl, cyano, --NH(lower alkyl), --N(lower alkyl).sub.2, lower alkoxy, lower alkylthio or carboxy;
- the term "alkenyl" refers to straight or branched chain radicals of 3 to 7 carbon atoms having one or two double bonds;
- the term "substituted alkenyl" refers to such straight or branched radicals of 3 to 7 carbons having one or two double bonds wherein a hydrogen has been replaced by a hydroxy, amino, halo, trifluoromethyl, cyano, --NH(lower alkyl), --N(lower alkyl).sub.2, lower alkoxy, lower alkylthio, or carboxy;
- the term "cycloalkyl" refers to saturated rings of 3 to 7 carbon atoms;
- the term "aryl" refers to phenyl, 1-naphthyl, and 2-naphthyl;
- the term "substituted aryl" refers to phenyl, 1-naphthyl;
- and 2-naphthyl having a substituent selected from lower alkyl, lower alkoxy, lower alkylthio, halo, hydroxy, trifluoromethyl, amino, --NH(lower alkyl), and --N(lower alkyl).sub.2, di- and tri-substituted phenyl, 1-naphthyl, or 2-naphthyl wherein said substituents are selected from methyl, methoxy, methylthio, halo, hydroxy, and amino;
- the term "heteroaryl" refers to unsaturated monocyclic rings of 5 or 6 atoms containing one or two O and S atoms and/or one to four N atoms provided that the only other atoms in said monocyclic ring are C atoms and that the total number of O,S and N atoms is four or less and bicyclic rings wherein the five or six membered ring as defined above is fused to a phenyl or pyridyl ring, said heteroaryl ring is attached by way of an available carbon or nitrogen atom;
- and said monocyclic or bicyclic ring can be substituted at an available carbon atom by lower alkyl of 1 to 4 carbons, halo, hydroxy, benzyl, or cyclohexylmethyl, or can be substituted at an available nitrogen atom by benzyloxymethyl, p-toluene sulfonyl, 2,4-dinitrophenyl, lower alkyl of 1 to 4 carbons, benzyl or benzhydryl;
- the term "lower alkyl" refers to straight or branched chain radicals having one to four carbons;
- the term "substituted lower alkyl" refers to such straight or branched chain radicals having one to four carbons wherein one hydrogen has been replaced by a hydroxy, amino, halo, trifluoromethyl, cyano, --NH(lower alkyl), --N(lower alkyl).sub.2, lower alkoxy, lower alkylthio, or carboxy;
- the terms "lower alkoxy" and "lower alkylthio" refer to such lower alkyl groups as defined above attached to an oxygen or sulfur;
- and
- the term "halo" refers to chloro, bromo, fluoro, and iodo.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of the formula ##STR59##
A compound of the formula:
- ##STR61## including a pharmaceutically acceptable salt thereof wherein:
- R.sub.1 is hydrogen or ##STR62## R.sub.2 is hydrogen, alkyl, cycloalkyl-(CH.sub.2).sub.m --, substituted alkyl, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or heteroaryl-(CH.sub.2).sub.p --;
- n is zero or one;
- m is zero or an integer from 1 to 6;
- p is an integer from 1 to 6;
- R.sub.3 is alkyl, substituted alkyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or heteroaryl-(CH.sub.2).sub.m --;
- X.sub.1 is ##STR63## R.sub.4 and R.sub.6 are both hydrogen, or one is hydrogen and the other is alkyl, substituted alkyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or heteroaryl-(CH.sub.2).sub.m --;
- R.sub.10 is hydrogen, alkyl, substituted alkyl, aryl-(CH.sub.2).sub.p --, or substituted aryl-(CH.sub.2).sub.p --;
- R.sub.12 is hydrogen, alkyl, substituted alkyl, aryl-(CH.sub.2).sub.m --, or substituted aryl-(CH.sub.2).sub.m --;
- the term "alkyl" refers to straight and branched chain radicals having one to seven carbon atoms;
- the term "cycloalkyl" refers to saturated rings of 4 to 7 carbon atoms;
- the term "substituted alkyl" refers to such straight and branched chain radicals having to 1 to 7 carbon atoms wherein one or more hydrogens have been replaced by a hydroxy, amino, halo, trifluoromethyl, --NH(lower alkyl of 1 to 4 carbons), --N(lower alkyl of 1 to 4 carbons).sub.2, lower alkoxy of 1 to 4 carbons, or lower alkylthio of 1 to 4 carbons;
- the term "aryl" refers to phenyl, 1-naphthyl, and 2-naphthyl;
- the term "substituted aryl" refers to phenyl, 1-naphthyl and 2-naphthyl having a substituent selected from lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, halo, hydroxy, trifluoromethyl, amino, --NH(lower alkyl of 1 to 4 carbons), and --N(lower alkyl of 1 to 4 carbons).sub.2, and di- and tri- substituted phenyl, 1-naphthyl, and 2-naphthyl wherein said substituents are selected from methyl, methoxy, methylthio, halo, hydroxy, and amino;
- and
- the term "heteroaryl" refers to unsaturated monocyclic rings of 5 of 6 atoms containing one or two O and S atoms and/or one to four N atoms provided that the only other atoms in said monocyclic ring are C atoms and that the total number of O,S, and N atoms is four or less and bicyclic rings wherein the five or six membered ring as defined above is fused to a phenyl or pyridyl ring, said heteroaryl ring is attached by way of an available carbon or nitrogen atom;
- and said monocyclic or bicyclic ring can be substituted at an available carbon atom by a lower alkyl of 1 to 4 carbons, halo, hydroxy, benzyl, or cyclohexylmethyl, or can be substituted at an available nitrogen atom by benzyloxymethyl, p-toluene sulfonyl, 2,4-dinitrophenyl, lower alkyl of 1 to 4 carbons, benzyl, or benzhydryl.
A compound of the formula ##STR64## and pharmaceutically acceptable salts thereof wherein:
- R.sub.1 is hydrogen, ##STR65## or R.sub.18 --S--;
- R.sub.2 and R.sub.19 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl-(CH.sub.2).sub.m --, substituted alkyl, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m --;
- n is zero or one provided that n must be zero when R.sub.2 and R.sub.19 are both other than hydrogen;
- m is zero or an integer from 1 to 6;
- R.sub.3 is alkyl, substituted alkyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or heteroaryl-(CH.sub.2).sub.m --;
- R.sub.18 is alkyl, substituted alkyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, or --S--R.sub.18 completes a symmetrical disulfide wherein R.sub.18 is of the formula ##STR66## X.sub.1 is of the formula ##STR67## R.sub.4 and R.sub.5 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m --, or one of R.sub.4 and R.sub.5 is hydrogen and the other is hydroxy, or R.sub.4 and R.sub.5 together with the carbon to which they are attached complete a keto substituent;
- R.sub.6 and R.sub.10 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, cycloalkyl-(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m --;
- R.sub.7 and R.sub.11 are independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, cycloalkyl -(CH.sub.2).sub.m --, aryl-(CH.sub.2).sub.m, substituted aryl -(CH.sub.2).sub.m --, and heteroaryl-(CH.sub.2).sub.m --;
- b is zero or one;
- R.sub.12 is hydrogen, alkyl, substituted alkyl, aryl-(CH.sub.2).sub.m --, substituted aryl-(CH.sub.2).sub.m --, heteroaryl-(CH.sub.2).sub.m --, or ##STR68## R.sub.14 is hydrogen, lower alkyl, cycloalkyl, or phenyl;
- R.sub.15 is hydrogen, lower alkyl, lower alkoxy or phenyl;
- the term "alkyl" refers to straight and branched chain radicals having one to seven carbon atoms;
- the term "substituted alkyl" refers to such straight or branched chain radicals of 1 to 7 carbons wherein one or more hydrogens have been replaced by a hydroxy, amine, halo, trifluoromethyl, cyano, --NH(lower alkyl), --N(lower alkyl).sub.2, lower alkoxy, lower alkylthio or carboxy;
- the term "alkenyl" refers to straight or branched chain radicals of 3 to 7 carbon atoms having one or two double bonds;
- the term "substituted alkenyl" refers to such straight or branched radicals of 3 to 7 carbons having one or two double bonds wherein a hydrogen has been replaced by a hydroxy, amine, halo, trifluoromethyl, cyano, --NH(lower alkyl), --N(lower alkyl).sub.2, lower alkoxy, lower alkylthio, or carboxy;
- the term "cycloalkyl" refers to saturated rings of 3 to 7 carbon atoms;
- the term "aryl" refers to phenyl, 1-naphthyl, and 2-naphthyl;
- the term "substituted aryl" refers to phenyl, 1-naphthyl, and 2-naphthyl having a substituent selected from lower alkyl, lower alkoxy, lower alkylthio, halo, hydroxy, trifluoromethyl, amine, --NH(lower alkyl), and --N(lower alkyl).sub.2, di- and tri-substituted phenyl, 1-naphthyl, or 2-naphthyl wherein said substituents are selected from methyl, methoxy, methylthio, hale hydroxy, and amine;
- the term "heteroaryl" refers to unsaturated monocyclic rings of 5 or 6 atoms containing one or two O and S atoms and/or one to four N atoms provided that the only other atoms in said monocyclic ring are C atoms and that the total number of O,S, and N atoms is four or less and bicyclic rings wherein the five or six membered ring as defined above is fused to a phenyl or pyridyl ring, said heteroaryl ring is attached by way of an available carbon or nitrogen atom;
- and said monocyclic or bicyclic ring can be substituted at an available carbon atom by lower alkyl of 1 to 4 carbons, halo, hydroxy, benzyl, or cyclohexylmethyl, or can be substituted at an available nitrogen atom by benzyloxymethyl, p-toluene sulfonyl, 2,4-dinitrophenyl, lower alkyl of 1 to 4 carbons, benzyl or benzhydryl;
- the term "lower alkyl" refers to straight or branched chain radicals having one to four carbons;
- the term "substituted lower alkyl" refers to such straight or branched chain radicals having one to four carbons wherein one hydrogen has been replaced by a hydroxy, amino, halo, trifluoromethyl, cyano, --NH(lower alkyl), --N(lower alkyl).sub.2, lower alkoxy, lower alkylthio, or carboxy;
- the terms "lower alkoxy" and "lower alkylthio" refer to such lower alkyl groups as defined above attached to an oxygen or sulfur;
- and
- the term "halo" refers to chloro, bromo, fluoro, and iodo.
A compound of the formula ##STR69## and pharmaceutically acceptable salts thereof wherein:
- R.sub.1 is hydrogen or H.sub.3 C--C(O)--;
- R.sub.2 is benzyl, (2-thienyl)methyl, or straight or branched chain alkyl of 1 to 5 carbons;
- R.sub.6 and R.sub.7 are both methyl;
- and
- R.sub.10 and R.sub.11 are both hydrogen or one is hydrogen and the other is methyl.
Dependencies are inferred from the claim text.